Table 2.

Clinical efficacy of onychomycosis treatment

Group	Cases, n	Efficacy rate, n
		8th week	16th week	24th week
Group A
Combination	21	21	20	19
Control	21	17	17	19
χ2		4.421	2.043	<0.001
P		>0.05	>0.05	>0.05
Group B
Combination	21	20	19	21
Control	21	13	14	11
χ2		6.929	3.535	13.125
P		<0.05	>0.05	<0.05

Group A: Mild to moderate disease severity; Group B: Severe disease severity.